JPET #172338

Introduction
JPET #172338 constructs were sequenced by the Nucleic Acid Protein Service Unit at the University of British Columbia (Vancouver, BC, Canada) , and the identity of plasmids was confirmed by comparing their sequence with published sequence.
HepG2
Cell Culture. HepG2 human hepatocellular carcinoma cells were purchased from American Type Culture Collection (Manassas, VA), and grown in minimum essential medium (MEM) supplemented with 2 mM L-glutamine, 100 U/ml penicillin G, 100 µg/ml streptomycin, and 10% v/v heat-inactivated fetal bovine serum. Cells were cultured in T-75 culture flasks and maintained at 37°C in a humidified incubator with 95% air and 5% CO 2 .
Culture medium was changed every two or three days, and cells were sub-cultured weekly.
Lactate Dehydrogenase (LDH) Assay. The LDH assay was performed essentially as described previously (Rajaraman et al., 2006) . Human PXR-transfected cells were treated with culture medium (vehicle control), G. biloba extract (200, 400, 600, or 800 µg/ml), dextran (1% v/v; negative control), or Triton ® X-100 (1% v/v; positive control). At the end of the 24 h treatment period, culture medium was collected and cells were lysed. To determine intracellular LDH release, 5 μ l aliquot of culture medium or 1 μ l aliquot of cell lysate was transferred into the wells of a 96-well microplate containing 95 μ l or 99 μ l of phosphate-buffered saline (pH 7.4), respectively. A 100 μ l of LDH reaction mixture (Cytotoxicity Detection Kit) was added into each well, and the plate was incubated for 30 min at room temperature. The absorbance was measured at 492 nm using a Multiskan Ascent ® microplate reader (Thermo Fisher Scientific Inc., Waltham, MA). The amount of LDH release into the culture medium was expressed as a percentage of the total cellular LDH content (sum of LDH content in culture medium and cell lysate).
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Reporter Gene Assay. PXR-dependent reporter activity was determined as described previously (Yeung et al., 2008) . HepG2 cells were seeded onto 24-well microplates at a density of 100,000 cells per well and in a volume of 0.5 ml culture medium. At 24 h after plating, cells were transfected for 24 h with 20 μ l of a transfection master mix containing FuGENE (Promega Corporation). Luminescence was measured using a GloMax TM 96 microplate luminometer (Promega Corporation). Luciferase activity was expressed as a normalized ratio of firefly luciferase to Renilla luciferase activity. Background luciferase activity was determined in HepG2 cells transfected with the empty vector, and the value was subtracted from the normalized luciferase activity. Fold-activation was calculated by dividing the net luciferase activity of the treatment group by that of the vehicle-treated control group.
This article has not been copyedited and formatted. The final version may differ from this version. PCR Primers. The sequences of primers for amplification of CYP3A4 cDNA (GenBank accession number NM_017460) were 5′-CCT-TAC-ACA-TAC-ACA-CCC-TTT-GGA-AGT-3′
(forward) and 5′-AGC-TCA-ATG-CAT-GTA-CAG-AAT-CCC-CGG-TTA-3′ (reverse) (Schuetz et al., 1996) , for amplification of human hypoxanthine phosphoribosyltransferase 1 (HPRT) cDNA (GenBank accession number NM_000194) were 5′-GAA-GAG-CTA-TTG-TAA-TGA-CC-3′ (forward) and 5′-GCG-ACC-TTG-ACC-ATC-TTT-G-3′ (reverse) (Qiu et al., 2007) , and for amplification of hPXR cDNA (GenBank accession number NM_003889) were 5′-CAA- GCG-GAA-GAA-AAG-TGA-ACG-3′ (forward) and 5′-CAC-AGA-TCT-TTC-CGG-ACC-TG-3′ (reverse) (Chang et al., 2003) . The primers were synthesized by Integrated DNA Technologies (Coralville, IA), and their specificity was verified by sequencing the purified PCR amplicons at the University of British Columbia Nucleic Acid Protein Service Unit.
Real-Time PCR Analysis. Real-time PCR analyses were performed using LightCycler ® (Roche Diagnostics). CYP3A4 and hPXR cDNA were amplified using the PCR conditions described previously (Yeung et al., 2008) , except that 2 mM of MgCl 2 was used in the amplification of hPXR cDNA and 1 ng of total cDNA was used in the amplification of CYP3A4
and hPXR cDNA. Statistical Analysis. Data were analyzed by one-way or two-way ANOVA, and when significant differences were detected, the Student Newman-Keuls multiple comparison test was performed (SigmaPlot 11.0, Systat Software, Inc., Chicago, IL). The level of statistical significance was set a priori at P < 0.05.
This article has not been copyedited and formatted. The final version may differ from this version. or 800 µg/ml) of G. biloba extract. Fig. 4A shows that G. biloba extract, at 30-200 µg/ml, had no effect on rPXR-dependent reporter gene activity, but it increased the activity in a log-linear manner at 400-800 µg/ml. At 400, 600, and 800 µg/ml, the extract increased rPXR activity by 13-, 16-, and 20-fold, respectively. Comparatively, G. biloba extract, at 30-100 µg/ml, had no effect on hPXR activity, but it increased the activity in a log-linear manner at 200-800 µg/ml. At 200, 400, 600, and 800 µg/ml concentrations, the extract increased hPXR activity by 13-, 27-, 34-, and 46-fold, respectively. Overall, G. biloba extract activated hPXR to a greater extent than rPXR.
Role of Terpene Trilactones in rPXR and hPXR Activation by G. biloba Extract in
Cultured HepG2 Cells. In this study, we used a G. biloba extract with known levels of terpene trilactones, namely 1.1% w/w ginkgolide A, 0.3% w/w ginkgolide B, 1.4% w/w ginkgolide C, 0.6% w/w ginkgolide J, and 2.8% w/w bilobalide. To determine whether these terpene trilactones were responsible for the increase in rPXR-and hPXR-dependent reporter gene activities by the extract, transfected HepG2 cells were treated with an individual terpene trilactone or a mixture of terpene trilactones at levels present in a PXR-activating concentration of the extract. A concentration of 400 µg/ml extract was selected because it was a log-linear concentration that activated both rPXR and hPXR. When tested at levels present in 400 µg/ml of G. biloba extract, ginkgolide A (4.4 µg/ml) activated rPXR by 6-fold and hPXR by 4-fold, whereas ginkgolide B (1.2 µg/ml), ginkgolide C (5.6 µg/ml), ginkgolide J (2.4 µg/ml), and bilobalide (11.2 µg/ml) had no effect on both receptors ( µg/ml concentration of the extract, ginkgolide A increased the reporter activity to 22% of the level in the rifampicin-treated group. As expected, PCN (negative control) had no effect.
Control analysis indicated that when the cells were transfected with SRC-1 alone, none of these treatment groups increased the reporter activity over the vehicle-treated control group.
Concentration-Dependent Effect of G. biloba Extract on PXR Target Gene
Expression in Cultured Human Hepatocytes. The next experiment was to characterize the effect of G. biloba extract on the transcription of a hPXR target gene (CYP3A4) in human hepatocytes in culture. The extract increased CYP3A4 mRNA expression in a log-linear manner at concentrations 25-200 µg/ml. At less than 25 µg/ml, the extract had minimal or no effect, whereas at 200 µg/ml, it increased the mRNA level to 11-fold in sample Hu1043 (Fig. 7A ) and 17-fold in sample Hu1108 (Fig. 7B) was determined in the same wells as those used for CYP3A4 mRNA analyses. At concentrations less than 50 µg/ml, the extract had minimal or no effect on testosterone 6β-hydroxylation, but at 50-200 µg/ml, it increased the catalytic activity in a log-linear manner by 4-to 11-fold in Hu1043 (Fig. 7C ) and 3-to 13-fold in Hu1108 (Fig. 7D ). In the same experiment, rifampicin increased testosterone 6β-hydroxylation by 51-fold in both Hu1043 and Hu1108 (data not shown).
Role of Terpene Trilactones in the Induction of a PXR Target Gene by G. biloba
Extract in Cultured Human Hepatocytes. To evaluate the role of terpene trilactones in CYP3A4 induction by G. biloba extract, cultured human hepatocytes were treated with each of the five individual terpene trilactones at levels present in a CYP3A4-inducing concentration (100 µg/ml) of the extract. Ginkgolide A (1.1 µg/ml) increased CYP3A4 mRNA levels by 5-fold in Hu1108 (Fig. 8A ) and 3-fold in Hu1138 (Fig. 8B) , whereas ginkgolide B (0.3 µg/ml), ginkgolide C (1.4 µg/ml), ginkgolide J (0.6 µg/ml), and bilobalide (2.8 µg/ml) had minimal or no effect on CYP3A4 mRNA expression in Hu1108 and Hu1138. Comparatively, ginkgolide A increased CYP3A4 mRNA level to a lesser extent than the increase (10-fold in Hu1108 and 4-fold in Hu1138) by G. biloba extract. Consistent with the mRNA data, ginkgolide A (1.1 µg/ml) increased CYP3A-catalyzed testosterone 6β-hydroxylation activity by 5-fold in Hu1108 (Fig. 8C) and 2-fold in Hu1138 (Fig. 8D) , which was less than the increase (8-fold in Hu1108 and 3-fold in Hu1138) by G. biloba extract (100 µg/ml). In contrast, ginkgolide B, ginkgolide C, ginkgolide J, and bilobalide did not affect CYP3A enzyme activity in both samples of human hepatocytes.
Effect of G. biloba Extract on hPXR Expression in Cultured Human Hepatocytes.
To assess whether G. biloba extract increases hPXR expression, hPXR mRNA levels were This article has not been copyedited and formatted. The final version may differ from this version. PXR shows considerable structural diversity among different species, and there is only 76% amino acid sequence homology between the ligand-binding domain of rat and human PXR (Jones et al., 2000) . Data from our luciferase reporter gene assay indicate that G. biloba extract activated rPXR to a lesser extent than hPXR, whereas ginkgolide A, at a concentration present in the extract, activated rPXR to a slightly greater extent than hPXR. This activation of rPXR provides a molecular basis for the increase in CYP3A expression by the extract in cultured rat hepatocytes (Rajaraman et al., 2006; Chang et al., 2006a; Deng et al., 2008) and rat liver (Shinozuka et al., 2002) . Structural studies suggest that the species-specific PXR activation could be attributed to several different amino acid residues in the ligand binding cavity of PXR.
Using site-directed mutagenesis assays, Phe305 in rPXR and Leu308 in hPXR, which are amino acids present in the flexible loop adjacent to the ligand binding cavity, have been identified as critical for the species-specific activation by several PXR ligands (Tirona et al., 2004) .
The expression of hPXR is subjected to regulation by certain drugs (Pascussi et al., 2000) . In conclusion, G. biloba extract is a hPXR agonist. It bound to hPXR and recruited SRC-1 coactivator to the receptor. Ginkgolide A, but not ginkgolide B, ginkgolide C, ginkgolide J, or bilobalide, contributed to hPXR activation by the extract, as assessed by an in vitro cell-based reporter gene assay, a mammalian two-hybrid assay, and target gene expression assays.
However, the effect of ginkgolide A did not involve binding to the ligand-binding domain of the receptor. While the extract had a greater effect on hPXR than on rPXR activity, ginkgolide A was also a contributor to the rPXR-activating effect of the extract. Although the extract affected hPXR function, it did not modulate hPXR expression, as assessed in cultured human hepatocytes.
Overall, our major findings provide insights into the biological and chemical mechanisms of hPXR activation by G. biloba extract. Recently, it has been suggested that PXR activation may be a new therapeutic strategy for Alzheimer's disease by increasing expression of P-glycoprotein (ABCB1) and clearance of brain β -amyloid (Hartz et al., 2010) . Given that G. biloba extract is a hPXR agonist and is capable of increasing P-glycoprotein (Yeung et al., 2008; Li et al., 2009 ), future studies are warranted to elucidate whether PXR activation may be a molecular mechanism underlying the purported use of the extract for neurodegenerative conditions such as Alzheimer's disease. In this context, the discovery that low micromolar concentrations of ginkgolide A activate hPXR may lead to an interest in drug development efforts.
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Data are expressed as a percentage of vehicle-treated control group and shown as mean ± S.E.M.
(n = 3). *Significantly different from the vehicle-treated control group (P < 0.05). 
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